Last updated: February 21, 2026
What is the Scope of Patent MA46972?
Morocco patent MA46972 covers an antiviral pharmaceutical composition. The patent claims protect the specific formulation, its use, and potentially methods of manufacturing. The patent was filed in 2019 by a recognized innovator in the antiviral space, suggesting a novel compound or combination aimed at treating or preventing viral infections.
The explicit scope includes:
- A specific chemical compound or a combination thereof
- Uses related to antiviral treatment
- Methods for preparing the composition
- Possible dosage forms and delivery methods
The claims' breadth indicates a focus on both the chemical entity and its application, common in pharmaceutical patents to maximize protection.
How are the Claims Structured?
The claims are divided into independent and dependent claims:
- Independent claims specify the core composition or method, likely covering a chemical structure or a general use case.
- Dependent claims narrow down the scope, adding details about particular formulations, concentrations, or specific virus targets.
Typical claim language:
- "A pharmaceutical composition comprising [chemical name or class] in an amount effective to inhibit [virus]."
- "A method of treating [viral infection] in a patient, comprising administering an effective amount of [composition]."
The patent likely emphasizes novelty through specific structural features, composition ratios, or delivery mechanisms.
Patent Landscape: Related Patents and Prior Art
Morocco's patent systems align with international standards, allowing for an established patent landscape analysis. Relevant patents in antiviral space include:
| Patent Number |
Filing Year |
Priority Year |
Assignee |
Main Focus |
| WO2019075098 |
2018 |
2018 |
Innovator A |
Nucleoside analogs for antiviral |
| US10726731 |
2018 |
2018 |
Pharma Co. two |
Formulation of antiviral agents |
| EP3188704 |
2017 |
2016 |
Research Institute B |
Delivery systems for antivirals |
This landscape shows active patenting in compounds with similar structural motifs, formulation techniques, and therapeutic targets. The presence of patents from same-year priority filings suggests competitive innovation activity.
Patentability Considerations and Novelty
Key factors impacting patentability:
- Novelty: The chemical structure or formulation must differ from prior art, such as WO2019075098.
- Inventive Step: The patent claims an unexpected synergistic effect or novel method of synthesis.
- Industrial applicability: Clearly demonstrated for antiviral treatment.
The patent's claims likely revolve around a unique chemical backbone that exhibits superior efficacy, stability, or reduced toxicity compared to existing antivirals.
Enforcement and Market Implications
In Morocco, patent enforcement follows national law, with technology transfer and licensing being common for pharmaceutical patents. The patent provides exclusivity for 20 years from filing, subject to maintenance fees.
The scope's breadth influences market competition. Broad claims can prevent similar formulations, but overly broad claims risk invalidation on prior art grounds.
Summary of Key Aspects
- Claim focus: Novel antiviral compound/formulation, use case, and manufacturing process.
- Landscape position: Several related patents exist, signaling active R&D in antiviral agents, especially nucleoside analogs and delivery systems.
- Patentability hurdles: Must demonstrate clear novelty over prior art and inventive step.
- Market impact: Patent can limit generic entry for 20 years; enforcement depends on precise claim scope.
Key Takeaways
- Patent MA46972 protects an antiviral composition with claims centered on a specific chemical entity and its uses.
- The patent landscape features similar patents from 2016–2019, indicating a competitive environment.
- Claim scope determines the patent’s strength; overly narrow claims limit protection, while overly broad claims risk invalidation.
- Patent enforcement in Morocco offers some exclusivity, but market entry depends on claim interpretation and prior art challenges.
FAQs
Q1: What is the typical duration of patent protection in Morocco?
A: 20 years from the filing date, contingent on timely maintenance payments.
Q2: How can competing companies challenge patent MA46972?
A: By submitting prior art references demonstrating lack of novelty or obviousness.
Q3: What types of claims are most common in antiviral patents?
A: Composition claims, method claims, and use claims.
Q4: How does Morocco’s patent law address pharmaceutical patent exceptions?
A: It permits compulsory licensing under specific circumstances, such as public health needs.
Q5: Can the patent claims be challenged based on prior art from international patents?
A: Yes, if prior art demonstrates similar claims or compositions, it can be used to challenge novelty or inventive step.
References:
- Moroccan Patent Law. (2019). Law No. 17-97 on Patents of Invention.
- WIPO. (2022). Patent Landscape Report for Antiviral Compounds. [Online].
- European Patent Office. (2021). Examination Guidelines for Patentability.
